This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A Third Look at the Skylark study and discussing Zuranolone in postpartum depression (PPD)
Ticker(s): SAGE, BIIBWho's the expert?
Institution: Inova Health
- Assistant Professor of Medical Education at the University of Virginia; Operations Director for Quality of the Obstetrics and Gynecology Department at Inova Fairfax Medical Campus.
- Manages 30 patients a month with post-op pain.
- Manages 220 patients with PPD
- Special interest in the management of fibroids, abnormal uterine bleeding, permanent and nonpermanent contraception, and minimally-invasive gynecologic surgery.
Interview GoalDiscussing Zuranolone in postpartum depression (PPD) after Skylark study: Currently approved for IV but this was oral. Generic name = (SAGE-217/BIIB125)
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
